We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ionis Pharmaceuticals
IONS
$9.14B
| – | – |
-24,715
| Closed | -$1.62M |
|
327
IQVIA
IQV
$40.5B
| – | – |
-9,400
| Closed | -$1.79M |
|
328
Iridium Communications
IRDM
$4.81B
| – | – |
-31,800
| Closed | -$555K |
|
329
iRhythm Holdings
IRTC
$3.86B
| – | – |
-4,386
| Closed | -$754K |
|
330
Intuitive Surgical
ISRG
$130B
| – | – |
-2,300
| Closed | -$1.03M |
|
331
Janus International
JBI
$732M
| – | – |
-20,222
| Closed | -$200K |
|
332
Johnson Controls International
JCI
$85.6B
| – | – |
-23,500
| Closed | -$2.58M |
|
333
JD.com
JD
$42.9B
| – | – |
-5,891
| Closed | -$206K |
|
334
Keurig Dr Pepper
KDP
$42.3B
| – | – |
-119,700
| Closed | -$3.05M |
|
335
Kirby Corp
KEX
$7.77B
| – | – |
-2,513
| Closed | -$210K |
|
336
Korn Ferry
KFY
$4.26B
| – | – |
-10,600
| Closed | -$742K |
|
337
Kimberly-Clark
KMB
$37.5B
| – | – |
-14,713
| Closed | -$1.83M |
|
338
Knight Transportation
KNX
$11.4B
| – | – |
-8,900
| Closed | -$352K |
|
339
Coca-Cola
KO
$380B
| – | – |
-20,400
| Closed | -$1.35M |
|
340
Kroger
KR
$36.3B
| – | – |
-30,400
| Closed | -$2.05M |
|
341
Kohl's
KSS
$2.16B
| – | – |
-36,600
| Closed | -$563K |
|
342
Kontoor Brands
KTB
$4.87B
| – | – |
-3,500
| Closed | -$279K |
|
343
Loews
L
$24.6B
| – | – |
-2,600
| Closed | -$261K |
|
344
SEALSQ Corp
LAES
$521M
| – | – |
-13,800
| Closed | -$51.6K |
|
345
nLIGHT
LASR
$3.57B
| – | – |
-10,961
| Closed | -$325K |
|
346
Lazard
LAZ
$4.21B
| – | – |
-6,366
| Closed | -$336K |
|
347
Liberty Broadband Class C
LBRDK
$4.72B
| – | – |
-4,400
| Closed | -$280K |
|
348
Liberty Global Class A
LBTYA
$3.49B
| – | – |
-14,234
| Closed | -$163K |
|
349
Liberty Energy
LBRT
$2.89B
| – | – |
-21,600
| Closed | -$267K |
|
350
Liberty Global Class C
LBTYK
$3.4B
| – | – |
-22,540
| Closed | -$265K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.